Search - tctmd.com

Displaying 581 - 600 of 1047

Sort: Relevancy | Date

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

Presentation TVT 2019

3-Dimensional Intracardiac Echocardiography to Guide Structural Heart Interventions

Presenter: Carlos Sanchez

June 14, 2019

Presentation TVT 2019

Plenary Lecture — Tricuspid Valve Interventions: A Voyage of Discovery

Presenter: Rebecca Hahn

June 12, 2019

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

Todd Neale

June 12, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve

Shelley Wood

May 27, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

Presentation ARCH 2019

Catheter Based Therapies After Surgical Mitral Interventions

Presenter: Alan Zajarias

April 12, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

Advertisement

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

3-Dimensional Intracardiac Echocardiography to Guide Structural Heart Interventions

Plenary Lecture — Tricuspid Valve Interventions: A Voyage of Discovery

Potential Warning Signs Seen for NOAC Use After TAVR

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

TAVR Operators: Can One Do It All or Are Two Still Justified?

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

TCTMD’s Top 10 Most Popular Stories for May 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Newer-Generation MitraClip XTR Shows Promise, but Beware the Learning Curve

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Latest Observational Data Support TAVR Durability Through 7 Years

Catheter Based Therapies After Surgical Mitral Interventions

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content